5170.0: Wednesday, November 15, 2000: 2:30 PM-4:00 PM | ||||
| ||||
| See individual abstracts for presenting author's disclosure statement. | ||||
| Learning Objectives: Refer to the individual abstracts for learning objectives | ||||
| Gabrielle Denmead | ||||
| Effect of a behavioral health carve-out on seven-month ASI outcomes Matthew Urato, MA, Larson Mary Jo, PhD, MPH, Kevin Smith, MA, Stephen Soldz, PhD | ||||
| Impact of Managed Care on Chemical Dependency Treatment: Key Variations within the Oregon Health Plan over Five Years' Implementation Katherine E. Laws, BA, Roy M. Gabriel, Phd | ||||
| Differences in drug use, treatment services utilization, and 6-month post-treatment outcomes between managed and unmanaged publicly funded adolescent AOD users Brooke S. Harrow, PhD, Laura Smart, PhD, Linda E. Kasten, MA | ||||
| Levels and quantity of care authorized for alcohol abuse/dependent patients by a managed behavioral healthcare organization Evangeline R Danseco, PhD, David T Levy, PhD, Paul R Marques, PhD, Ted R Miller, PhD, Eduardo Romano, PhD, Laureen Teti, PhD, Geetha Waehrer, PhD, Eduard Zaloshnja, PhD | ||||
| Will managed care promote linkage of substance abusers to ongoing treatment Mary Jo Larson, PhD, Linda E Kasten, MA, Mary Btrolin, PhD | ||||
| Sponsor: | Alcohol, Tobacco, and Other Drugs | |||
| Cosponsors: | Lesbian, Gay, Bisexual, and Transgender Caucus of Public Health Workers; Medical Care; Mental Health; Socialist Caucus | |||